Compass Pathways Advances FDA Collaboration and Fast-Track Development for COMP360 in TRD and PTSD

Earnings Conference Call Highlights: COMPASS Pathways (CMPS) Second Quarter 2… Read more » Compass Pathways Advances FDA Collaboration and Fast-Track Development for COMP360 in TRD and PTSD

FDA Releases 200+ Complete Response Letters to Boost Drug Approval Clarity

WASHINGTON, D.C. — A significant step towards enhancing openness an… Read more » FDA Releases 200+ Complete Response Letters to Boost Drug Approval Clarity

Trump's Drug Tariffs May Boost Costs and Cause Shortages, WarnExperts

During a political fundraiser dinner on Tuesday evening, President Donald Tr… Read more » Trump's Drug Tariffs May Boost Costs and Cause Shortages, WarnExperts